摘要
溶血尿毒综合征(hemolytic uremic syndrome,HUS)是儿童急性肾衰竭最常见的原因,属于全身性血栓性微血管病,临床以微血管病性溶血性贫血、血小板减少和急性肾衰竭为特征。以往根据有无腹泻症状将HUS分为腹泻后HUS(D HUS,即典型HUS)和非腹泻后HUS(D—HUS,即非典型HUS)。其中非典型HUS占儿童HUS的5%~10%,
出处
《中华儿科杂志》
CAS
CSCD
北大核心
2012年第4期286-289,共4页
Chinese Journal of Pediatrics
参考文献39
-
1Besbas N,Karpman D,Landau D. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders[J].Kidney International,2006.423-431.
-
2Waters AM,Licht C. aHUS caused by complement dysregulation:new therapies on the horizon[J].Pediatric Nephrology,2011.41-57.
-
3Keir L,Coward RJ. Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy[J].Pediatric Nephrology,2011.523-533.doi:10.1007/s00467-010-1637-4.
-
4Kavanagh D,Goodship T. Genetics and complement in atypical HUS[J].Pediatric Nephrology,2010.2431-2442.
-
5Venables JP,Strain L,Routledge D. Atypical haemolytic uraemic syndrome associated with a hybrid complement gene[J].PLOS MEDICINE,2006.e431.doi:10.1371/journal.pmed.0030431.
-
6Bienaime F,Dragon-Durey MA,Regnier CH. Mutations in components of complement influence the outcome of factor Ⅰ-associated atypical hemolytic uremic syndrome[J].Kidney International,2010.339-349.doi:10.1038/ki.2009.472.
-
7Chan MR,Thomas CP,Torrealba JR. Recurrent atypical hemolytic uremic syndrome associated with factor Ⅰ mutation in a living-related renal transplant recipient[J].American Journal of Kidney Diseases,2009,(2):321-326.doi:10.1053/j.ajkd.2008.06.027.
-
8Cruzado JM,de Cordoba SR,Melilli E. Successful renal transplantation in a patient with atypical hemolytic uremic syndrome carrying mutations in both factor Ⅰ and MCP[J].American Journal of Transplantation,2009.1477-1483.doi:10.1111/j.1600-6143.2009.02647.x.
-
9Esparza-Gordillo J,Jorge EG,Garrido CA. Insights into hemolytic uremic syndrome:segregation of three independent predisposition factors in a large,multiple affected pedigree[J].Molecular Immunology,2006.1769-1775.
-
10Kavanagh D,Richards A,Noris M. Characterization of mutations in complement factor Ⅰ (CFI) associated with hemolytic uremic syndrome[J].Molecular Immunology,2008.95-105.doi:10.1016/j.molimm.2007.05.004.
同被引文献47
-
1Waters AM,Licht C. Ahus caused by complement dysregulation:new therapies on the horizon [J]. Pediatr Nephrol, 2011,26:41-57.
-
2Moore I, Strain L, Pappworth I,et al. Association of factor Hautoantibodies with deletions of CFHR1,CFHR3 , CFHR4, andwith mutations in CFH,CFI,CD46,and C3 in patients withatypical hemolytic uremic syndrome [J] . Blood, 2010,115:379-387.
-
3Ariceta G, Besbas N, Johnson S, et al. European Paediatric StudyGroup for HUS. Guideline for the investigation and initial therapyof diarrhea-negative hemolyticuremic syndrome [J] . PediatrNephrol, 2009, 24: 687-696.
-
4Filler G,Radhakrishnan S,Strain L,et al. Challenges in themanagement of infantile factor H associated hemolytic uremicsyndrome[J]. Pediatr Nephrol, 2004, 19: 908-911.
-
5Dragon-Durey MA,Loirat C,Cloarec S,et al. Anti-Factor Hautoantibodies associated with atypical hemolytic uremic syndrome[J]. J Am Soc Nephrol, 2005,16: 555-563.
-
6Dragon-Durey MA, Sethi SK, Bagga A, et al. Clinical features ofanti-factor H autoantibody-associated hemolytic uremic syndrome[J]. J Am Soc Nephrol, 2010, 21:2180-2187.
-
7Boyer 0,Balzamo E, Charbit M, et al. Pulse cyclophosphamidetherapy and clinical remission in atypical hemolytic uremicsyndrome with anti-complement factor H autoantibodies [J]. Am JKidney Dis, 2010, 55: 923-927.
-
8Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, etal. Differential impact of complement mutations on clinicalcharacteristics in atypical hemolytic uremic syndrome[J]. J AmSoc Nephrol, 2007,18: 2392-2400.
-
9Huang Y,Liu Z,Huang H,et al. Effects of mycophenolic acid onendothelial cells [J] . Int Immunopharmacol, 2005,5: 1029-1039.
-
10Loirat C, Fr6meaux-Bacchi V. Atypical hemolytic uremic syndrome [J]. Orphanet J Rare Dis, 2011, 6:60.
引证文献2
-
1管娜,刘晓宇,姚勇,杨霁云,王芳,肖慧捷,丁洁,赵明辉,于峰.抗H因子自身抗体相关性溶血尿毒综合征临床特点、治疗及随访[J].中华儿科杂志,2014,52(3):223-226. 被引量:8
-
2易翠莉,余自华.补体旁路途径失调非典型溶血尿毒综合征的发病机制及诊疗进展[J].中华儿科杂志,2016,54(7):554-557. 被引量:4
二级引证文献12
-
1孔昕欣,孙书珍,李倩,陈元,周爱华,王莉,姚秀俊.抗H因子抗体阳性溶血尿毒综合征7例分析[J].山东大学学报(医学版),2022,60(4):82-86. 被引量:1
-
2李海霞.补体系统与肾脏疾病研究现状及展望[J].中华检验医学杂志,2015,38(9):580-582. 被引量:5
-
3郑悦,吴玉斌,赵成广,杜悦.单中心血浆置换治疗小儿溶血尿毒综合征疗效评价[J].中国实用儿科杂志,2015,30(11):859-863. 被引量:2
-
4王有枝,李彦豪,梅雀林,刘秋松.原发性肝癌肝动脉化疗栓塞术后继发溶血性尿毒综合征3例并文献复习[J].介入放射学杂志,2016,25(6):543-545. 被引量:5
-
5易翠莉,赵锋,邱红珠,王腊梅,黄隽,聂晓晶,余自华.非典型溶血尿毒综合征汉族儿童补体基因变异分析[J].中华儿科杂志,2017,55(8):624-627. 被引量:2
-
6谢婷婷,余自华.依库珠单抗在儿童非典型溶血尿毒综合征中的应用[J].中华实用儿科临床杂志,2018,33(17):1351-1353. 被引量:4
-
7林甜甜,陈朝英.17例儿童血栓性微血管病临床分析[J].临床儿科杂志,2019,37(3):188-191. 被引量:1
-
8王秀丽,吴玉斌.儿童重症风湿免疫性疾病的血液净化治疗[J].中国实用儿科杂志,2019,34(12):997-1001. 被引量:4
-
9李广波,秦娜,刘翠华,田明,张书锋,曹广海,魏磊,刘平,刘钧菲.儿童非典型溶血尿毒综合征临床特点、治疗及预后[J].甘肃医药,2019,38(8):697-699.
-
10林矜,余自华.补体旁路途径失调非典型溶血尿毒综合征的诊断和治疗[J].罕少疾病杂志,2022,29(5):1-5. 被引量:3
-
1李秀勇,王秀丽,史万祥,于兰.体外循环致溶血性尿毒症综合征一例[J].中国心血管病研究,2010,8(5):371-372.
-
2赵水爱,陈一芳,刘爱民,毛建华.儿童溶血尿毒综合征危险因素分析[J].中华急诊医学杂志,2008,17(11):1198-1199.
-
3王希春,高燕,蒋文茜.特发性节段性网膜梗死1例分析[J].中国误诊学杂志,2011,11(3):625-625.
-
4胡俊.伴有腹泻症状急性阑尾炎的诊断体会[J].中国医药指南,2015,13(16):202-202. 被引量:2
-
5陈恩宏.双醋瑞因联合塞来昔布治疗膝骨关节炎疗效及安全性观察[J].新中医,2015,47(7):147-149. 被引量:8
-
6张学华.伴有腹泻症状急性阑尾炎的诊断探究[J].世界最新医学信息文摘,2016,16(44). 被引量:3
-
7丛莉莹,史晓东.伴有腹泻的婴幼儿急性阑尾炎误诊分析[J].中国民间疗法,2011,19(3):64-64. 被引量:1
-
8孙彬,王笑云.血栓性微血管病的肾损害[J].中国实用内科杂志,2002,22(9):524-527. 被引量:1
-
9杨坚,史晨辉.MMPs及相关细胞因子在骨性关节炎中的研究进展[J].农垦医学,2009,31(5):448-451. 被引量:16
-
10陈丽芳,缪应雷.急性肠系膜上静脉血栓形成并肠梗阻[J].中华消化杂志,2009,29(1):53-53.